HLS Therapeutics Inc. Opens the Market

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\nHLS Therapeutics Inc. Opens the Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, March 20, 2019\n\n\n\nTORONTO, March 20, 2019 /CNW/ - William Wells, Executive Chairman, alongside Greg Gubitz, CEO, HLS Therapeutics Inc. (HLS), joined joined Dani Lipkin, Innovation Sector Head, Capital Formation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Formed in 2015, HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS Therapeutics Inc. graduated and commenced trading on Toronto Stock Exchange on February 7, 2019.\n\n \n \n\n \n\n\n\nSOURCE TMX Group Limited\n\n\n\nView original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/20/c2441.html\n\n\n\n\nCopyright CNW Group 2019","length":2446,"tagName":"div"}]

More updates from Hls Therapeutics, Inc.